Concepedia

Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial

Jørgen Vestbo, Alberto Papi, Massimo Corradi, Viktor Blazhko, Isabella Montagna, Catherine Francisco, Géraldine Cohuet, Stefano Vezzoli, Mario Scuri, Dave Singh

The Lancet · 2017 · 442 citations · 21 references

DOIFull text

Open access

Concepts

References

21

Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease

Gavin C. Donaldson · Thorax · 2002 · 2.3K citations · Full text

, , +17

Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD

Jadwiga A. Wedzicha, Donald Banerji, Kenneth R. Chapman et al. · New England Journal of Medicine · 2016 · 870 citations · Full text

, , +17

Effect of Pharmacotherapy on Rate of Decline of Lung Function in Chronic Obstructive Pulmonary Disease: Results from the TORCH Study

Bartolomé R. Celli, Nicola E. Thomas, Julie A. Anderson et al. · American Journal of Respiratory and Critical Care Medicine · 2008 · 746 citations

, , +17

Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials

Steven Pascoe, Nicholas Locantore, Mark T. Dransfield et al. · The Lancet Respiratory Medicine · 2015 · 733 citations

, , +17

Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.

Shawn D. Aaron, Katherine L. Vandemheen, Dean Fergusson et al. · PubMed · 2007 · 654 citations

, , +17